Clinical Trial Update: Deposition of Inhaled Prolastin in Cystic Fibrosis Patients [Phase 2]

View source ↗

Summary

Phase 2 results were posted for a study evaluating deposition of inhaled Prolastin in cystic fibrosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Prolastin (alpha-1 proteinase inhibitor (human))

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2014-08-21